Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K251987

Rapid Aortic Measurements

iSchemaView, Inc.

Authorized purpose: Aortic and iliac artery segmentation, visualization, measurement, and longitudinal tracking as adjunctive physician decision support.

Modality
CT/CTA
Anatomy
Aorta, iliac arteries, and major branching vessels in the chest, abdomen, and/or pelvis
Decision
2025-09-23
FDA-cleared K243378

Rapid MLS

iSchemaview Inc.

Authorized purpose: Brain midline-shift measurement on adult non-contrast CT

Modality
CT/CTA
Anatomy
Brain
Decision
2025-05-28
FDA-cleared K243350

Rapid Neuro3D

iSchemaView, Inc.

Authorized purpose: Rapid Neuro3D analyzes adult head-and-neck CTA DICOM from the aortic arch to the vertex, removing bone, tissue, and venous vessels to generate 3D/2D neurovascular visualizations, including MIP, volume-rendered, and CPR views of carotid and vertebral arteries for trained physicians' lesion review and planning; results are not standalone clinical decisions.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-01-22
FDA-cleared K232156

Rapid ASPECTS (v3)

iSchemaView, Inc.

Authorized purpose: Adjunct assessment of early ischemic brain tissue injury and extent of disease in adult ischemic-stroke diagnostic imaging workup, typically within 24 hours of last known well

Modality
CT/CTA
Anatomy
Brain/head ASPECTS regions
Decision
2024-01-19
FDA-cleared K233512

Rapid (6.0)

iSchemaView, Inc.

Authorized purpose: Rapid Platform v6.0 is image-processing software for trained professionals that views, processes, and analyzes DICOM images from CT and MRI. It supports functional and dynamic datasets including CT perfusion, CT angiography, diffusion-weighted MRI, and dynamic contrast-enhanced CT or MRI, with maps and measurements for tissue perfusion, diffusion, and blood volume. Rapid CT-Perfusion and Rapid MR-Perfusion may aid physicians in selecting acute stroke patients with known occlusion of the intracranial internal carotid artery or proximal middle cerebral artery for endovascular thrombectomy, subject to the labeled imaging criteria, clinical requirements, and exclusions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain and intracranial vessels represented in CT perfusion, CTA, and MRI; tissue perfusion, diffusion, and contrast dynamics
Decision
2024-01-16
FDA-cleared K232436

Rapid SDH

iSchemaView, Inc.

Authorized purpose: Triage and notification of suspected hemispheric subdural hemorrhage (SDH) on non-enhanced head CT, in parallel with standard-of-care interpretation; not diagnostic.

Modality
CT/CTA
Anatomy
Head, specifically hemispheric subdural space
Decision
2023-10-25
FDA-cleared K230074

Rapid Aneurysm Triage and Notification

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists in routine-care workflow triage by flagging and prioritizing adult studies with suspected unruptured saccular brain aneurysms at least 4 mm in diameter; compressed previews are informational and not for diagnostic use.

Modality
CT/CTA
Anatomy
Brain and intracranial arteries
Decision
2023-07-27
FDA-cleared K222884

Rapid NCCT Stroke

iSchemaView, Inc.

Authorized purpose: Triage and notification for suspected intracranial hemorrhage and non-contrast CT large-vessel occlusion involving the ICA and MCA-M1.

Modality
CT/CTA
Anatomy
Brain/head, including ICH and ICA/MCA-M1 LVO findings.
Decision
2023-03-02
FDA-cleared K221456

Rapid ICH

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected IPH, IVH, SAH, and SDH findings in non-enhanced head CT images.

Modality
CT/CTA
Anatomy
Head/brain; suspected intraparenchymal, intraventricular, subarachnoid, and subdural intracranial hemorrhage.
Decision
2022-09-12
FDA-cleared K221248

Rapid LVO

iSchemaView Inc.

Authorized purpose: Assist hospital networks and trained radiologists with workflow triage by flagging and communicating suspected ICA or MCA-M1 large-vessel occlusion findings in head CTA images.

Modality
CT/CTA
Anatomy
Head/brain vasculature, specifically the intracranial ICA and MCA-M1 segments.
Decision
2022-05-31
FDA-cleared K200941

Rapid LVO

iSchemaView Inc.

Authorized purpose: Notification-only triage of adult head CTA for suspected large-vessel occlusion; results do not replace diagnostic interpretation.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-07-09
FDA-cleared K200760

Rapid ASPECTS

iSchemaView Inc.

Authorized purpose: Adjunct evaluation of extent of early ischemic brain injury in patients with known MCA or ICA occlusion during stroke imaging interpretation within 6 hours

Modality
CT/CTA
Anatomy
Brain/head ASPECTS regions
Decision
2020-06-26
FDA-cleared K182130

iSchemaView RAPID

iSchemaView, Inc.

Authorized purpose: iSchemaView RAPID processes CT perfusion, CTA, and MR studies to visualize and analyze diffusion and perfusion, including tissue blood-volume maps, and supports physician selection of eligible acute-stroke patients with known intracranial ICA or proximal MCA occlusion for thrombectomy.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain, intracranial vasculature, and perfusion regions
Decision
2018-12-27